PPP2R5D and hereditary elliptocytosis: In contrast, B56δ protein expression did not show any significant difference between pre-malignant livers at 11 months post-DEN treatment and untreated control livers for either WT or HE mice (Figure 9C), suggesting that the observed B56δ upregulation (Figure 9A) likely depends on a tumor-specific factor.